telehealthhigh engagement
Hims privacy fight shows the cost of scaling too fast
The Hims & Hers coverage and related privacy complaint discussion highlight a major risk for consumer-facing telehealth and subscription health businesses: using sensitive health data in ways that may conflict with privacy promises. This is a scaling, trust, and compliance story for founders in DTC healthcare software, especially where growth depends on marketing automation and ad-tech integrations.
Draft a post from this →AI-in-healthcaremedium engagement
Healthcare AI is winning by fitting into real workflows
Multiple market and partnership signals point to the same core theme: healthcare software is shifting from standalone AI tools toward embedded workflow automation inside EHR and clinical systems. The Redox-Lapsi Health collaboration, along with market coverage on AI in healthcare, cloud EHR expansion, and smart healthcare, all reinforce the integration-first thesis that matters to founders building software-enabled care businesses.
Draft a post from this →clinical-trialslow engagement
Clinical trials keep creating demand for healthtech infrastructure
A large set of ClinicalTrials.gov updates spans oncology, autoimmune disease, and other therapeutic areas, mostly from NCI and Janssen. While these are not startup funding events, they matter to healthtech founders building trial infrastructure, RWE platforms, patient matching, and clinical data tools because they show continued demand for digitally enabled research operations.
Draft a post from this →NIHlow engagement
NIH funding keeps the healthcare innovation pipeline alive
NIH RePORTER items span basic science, clinical implementation, and specialized translational work, from maternal cardiovascular outcomes to food safety response teams and neuroscience. These grants are not directly company financing, but they provide context for where future healthtech product opportunities and research partnerships may emerge.
Draft a post from this →